Home   HELP  /   AYUDA  /   求助 : help-desk@bctrials.org  /   (415) 476-5777 Click to print page  Print
Other options

view Contact Information

Contact Information for Olaparib and Durvalumab in Metastatic Triple Negative Breast Cancer

The sites for this trial are listed below.
If you speak with a site, please mention that you were referred by BreastCancerTrials.org

OHSU Knight Cancer Institute, Portland, OR,  97239

Contact person: Zahi Mitri, MD
Email: mitri@ohsu.edu